Physician profile
Lynt B Johnson
NPI 1114926565
$153,776.82
in general payments reported to CMS, 2019-2025
33 companies · $128K in 2025
The $128K reported for 2025 was more than what 99% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,405 · 2020: $2,862 · 2021: $322 · 2022: $679 · 2023: $6,867 · 2024: $11K · 2025: $128K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $109K · Travel and Lodging: $24K · Food and Beverage: $8,632 · Education: $4,067 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $108,785.00 |
| Travel and Lodging | $24,016.33 |
| Food and Beverage | $8,632.39 |
| Education | $4,066.69 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $129,339.55 | 2023-2025 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $8,820.35 | 2020-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $3,883.76 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Asensus Surgical, INC. | $3,481.38 | 2019 | |
| Veloxis Pharmaceuticals, INC. | $2,974.92 | 2019-2023 | Envarsus |
| Transmedics, INC. | $1,663.47 | 2025 | Organ Care System |
| Covidien Lp | $797.59 | 2019 | |
| Medtronic, INC. | $328.37 | 2021-2024 | Sonicision, Signia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $269.98 | 2022-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $269.70 | 2025 | Rezdiffra |
| Mallinckrodt Hospital Products INC. | $223.84 | 2020-2025 | Terlivaz |
| Shionogi INC | $212.57 | 2024-2025 | Fetroja |
| Alexion Pharmaceuticals, INC. | $193.68 | 2023-2025 | Ultomiris |
| Gilead Sciences, INC. | $171.67 | 2023-2025 | Livdelzi |
| Takeda Pharmaceuticals U.S.A., INC. | $169.99 | 2022-2023 | Livtencity |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $138.94 | 2024 | Irrisept |
| Intera Oncology, INC | $124.98 | 2025 | Intera |
| Sanofi-Aventis U.S. LLC | $113.65 | 2021 | |
| Aroa Biosurgery Incorporated | $104.21 | 2022 | |
| Becton, Dickinson and Company | $91.53 | 2022 | |
| Baxter Healthcare | $63.36 | 2023 | Tisseel, Floseal |
| Davol INC. | $55.05 | 2021 | |
| Merck Sharp & Dohme LLC | $45.70 | 2025 | Prevymis |
| Abbvie INC. | $43.93 | 2023 | |
| Astellas Pharma US INC | $30.41 | 2025 | Cresemba |
| Ethicon US, LLC | $28.22 | 2025 | Prolene, Surgicel Nu-Knit, Evarrest |
| Ipsen Biopharmaceuticals, INC | $25.83 | 2025 | Iqirvo |
| Teleflex LLC | $23.10 | 2023 | Quikclot |
| Intercept Pharmaceuticals, INC. | $19.97 | 2024 | |
| Stryker Corporation | $19.39 | 2023 | Spy-Phi System |
| Novo Nordisk INC | $18.95 | 2025 | Wegovy |
| Melinta Therapeutics, LLC | $15.83 | 2024 | Vabomere, Rezzayo |
| Potrero Medical, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynt Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.